Persistent Cutaneous Insulin Allergy Resulting From High-Molecular-Weight Insulin Aggregates

Cutaneous insulin allergy remains a clinical problem despite the use of highly purified human insulins. We used in vitro lymphocyte-transformation studies to examine the reactivity of various insulin formulations in diabetic patients with (n = 4) and without (n = 8) cutaneous allergies. Nonspecific response to concanavalin A demonstrated a >40-fold response in both groups. Control patients did not respond to the addition of commercial insulin preparations (stimulation index [SI] <4), whereas allergic patients had an 11-fold response to beef (P < 0.01), a 10-fold response to pork (P < 0.01), and a 6-fold response to human (P < 0.01) insulins. This response was limited to a single insulin manufacturer's preparations and was uniform in all three species tested. Efforts to identify the offending agent revealed no lymphoblast transformation when crystalline insulin was used or when commercial preparations were purified to a single peak by high-performance liquid chromatography (HPLC). Pure crystalline insulin dimers of beef, pork, and human species were tested; control subjects responded with mean Sis of 1.9,1.9, and 1.8, respectively, whereas allergic patients showed greater reactivity to beef (SI 7.3) and pork (S114.8). The lymphoblast-transformation response to crystalline human dimer was dose dependent with mean Sis of 0.9 at low concentration (2.8 ng/ml) and 19.2 at a higher concentration (20.4 ng/ml). The commercial insulin preparations were run on size-exclusion HPLC to determine high-molecular-weight aggregate content. Independent of species, a single manufacturer had products demonstrating aggregate levels 3- to 6-fold higher than those found in other manufacturers’ preparations. Our in vitro data suggest that insulin aggregates rather than native monomers cause cutaneous allergy and that antigenicity of commercial preparations correlates with the relative concentration of aggregates. In vivo testing is needed to confirm our results.

[1]  J. Chow,et al.  Physical Stability of Insulin Formulations , 1983, Diabetes.

[2]  M. Viswanathan,et al.  Insulin-specific IgE in serum of 67 diabetic patients against human insulin (Novo), porcine insulin, and bovine insulin. Four case reports. , 1983, Diabetes care.

[3]  Jen Sc.  Galenics of Insulin , 1987, Springer Berlin Heidelberg.

[4]  Tom L. Blundell,et al.  Insulin: The Structure in the Crystal and its Reflection in Chemistry and Biology by , 1972 .

[5]  B. Metzger,et al.  Cutaneous allergy to human (recombinant DNA) insulin. , 1984, JAMA.

[6]  P. Lieberman,et al.  Allergic reactions to insulin. , 1971, JAMA.

[7]  M. Feinglos,et al.  "INSULIN" ALLERGY DUE TO ZINC , 1979, The Lancet.

[8]  T. Adrian,et al.  AUTOIMMUNITY IN DIABETICS INDUCED BY HORMONAL CONTAMINANTS OF INSULIN , 1979, The Lancet.

[9]  H. Dvorak,et al.  Dermal hypersensitivity reactions to insulin: correlations of three patterns to their histopathology. , 1982, The Journal of allergy and clinical immunology.

[10]  E. J. Lennon,et al.  The incidence of skin reactivity to insulin in diabetic patients. , 1962, The Journal of allergy.

[11]  S. Shoelson,et al.  Products of Therapeutic Insulins in the Blood of Insulin-dependent (Type I) Diabetic Patients , 1985, Diabetes.

[12]  R. D. Lawrence.  LOCAL INSULIN REACTIONS. , 1925 .

[13]  P. Schellekens,et al.  Lymphocyte transformation in vitro. I. Tissue culture conditions and quantitative measurements. , 1968, Clinical and experimental immunology.

[14]  D. Robbins,et al.  Antibodies to Covalent Aggregates of Insulin in Blood of Insulin-Using Diabetic Patients , 1987, Diabetes.

[15]  T. Blundell,et al.  Receptor-binding region of insulin , 1976, Nature.

[16]  A. Lauritano,et al.  Evaluation of Patients With Local Reactions to Insulin With Skin Tests and In Vitro Techniques , 1987, Diabetes Care.

[17]  W. White,et al.  Severe delayed inflammatory reactions from injected insulin. Association with cell-mediated immunity. , 1983, The American journal of medicine.

[18]  W. Shelley,et al.  Chronic urticaria from isophane insulin therapy; sensitivity associated with noninsulin components in commercial preparations. , 1975 .

[19]  C. Kahn,et al.  Immunologic Reactions to Insulin: Insulin Allergy, Insulin Resistance, and the Autoimmune Insulin Syndrome , 1979, Diabetes Care.

[20]  P. Raskin,et al.  Cutaneous Complications of Chronic Continuous Subcutaneous Insulin Infusion Therapy , 1981, Diabetes Care.